End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- BRL | -.--% | -.--% | -.--% |
16/05 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/04 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Business Summary
Sales per Business
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Insulins
100.0
%
| 105 | 100.0 % | 118 | 100.0 % | +12.62% |
Sales per region
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brazil
100.0
%
| 105 | 100.0 % | 118 | 100.0 % | +12.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | 16/19/16 | |
Luciano Vilela
CTO | Chief Tech/Sci/R&D Officer | - | 20/14/20 |
Chief Operating Officer | - | - | |
Corporate Officer/Principal | - | - | |
Comptroller/Controller/Auditor | - | - | |
Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 01/14/01 | |
Director/Board Member | 84 | 13/15/13 | |
Director/Board Member | 81 | 16/13/16 | |
Chairman | 80 | 16/13/16 | |
Director/Board Member | - | 18/15/18 | |
Director/Board Member | 85 | 16/13/16 | |
Newton de Souza
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,841,481 | 42,974,062 ( 33.88 %) | 0 | 33.88 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- BIOM3 Stock
- BIOM9 Stock
- Company Biomm S.A.